Skip to Content

Engineered Therapeutic Viruses can Target Abnormal RNA Splicing in Cancer

2022
Team Members:
  • Benjamin Dubner
Advisors:
  • Constanza Miranda, Ph.D.
Sponsors:
  • William Dalton, M.D., Ph.D.
  • Jonathan Ling, Ph.D.
  • Fatemeh Rajaii, M.D., Ph.D.

Read the Johns Hopkins University privacy statement here.

Accept